Drug-eluting coronary stents – focus on improved patient outcomes
Zehra Jaffery, Amit Prasad, John H Lee, Christopher J WhiteDepartment of Cardiovascular Diseases, The John Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, New Orleans, LA, USAAbstract: The development of stent has been a major advance in
Jaffery Z, Prasad A, Lee JH, White CJ
doaj
Comparative clinical evaluation of safety and efficacy of commonly used drug-eluting stents in coronary artery disease patients after angioplasty in South India: A retro-prospective multi-center study [PDF]
Vinoth Prabhu Veeramani +99 more
openalex +1 more source
Prediction of Coronary Artery Restenosis in Patients Undergoing Angioplasty
BACKGROUND AND OBJECTIVE: Coronary artery restenosis following angioplasty may lead to major unwanted cardiac events. This is one of the most important concerns of cardiologists.
F Ebrahimzadeh +3 more
doaj
Consistency of primary outcomes in evidence synthesis researches on drug-eluting stents for coronary artery disease. [PDF]
Lin X +16 more
europepmc +1 more source
Paclitaxel- and Sirolimus-Coated Balloons Versus Drug-Eluting Stents in Coronary Artery Disease: A Comprehensive Narrative Review. [PDF]
Gherasie FA +4 more
europepmc +1 more source
Impact of alirocumab on neoatherosclerosis formation and vessel healing after drug-eluting stent implantation in patients with acute myocardial infarction: a substudy of the PACMAN-AMI trial [PDF]
Ryota Kakizaki +17 more
openalex +1 more source
Patient-tailored Drug-eluting Stent Choice – A Solution for Patients with Diabetes [PDF]
Roxana Mehran +4 more
openalex +1 more source
Comparative outcomes of drug-eluting stents and drug-eluting balloons in treating in-stent restenosis. [PDF]
Mahajan N, Singal G, Sharma M.
europepmc +1 more source

